Table 1: Antibodies used in this study.

ABTIBODY

CLONE

DILUTION

CONTROL

VENDER

PLATFORM

MOC-31

MOC-31

RTU

Colon

Ventana

Ventana Ultra

AE1/3

AE1/AE3/pk26

RTU

Skin

Ventana

Ventana Ultra

E-cadherin

36

RTU

Breast

Ventana

Ventana Ultra

CK7

RN7

1:100

Breast

Leica

Leica Bond

CK20

Ks20.8

1:50

Colon

Leica

Leica Bond

CK5

D5/16B4 

RTU

Skin

Leica

Leica Bond

HMWCK

CK34βE12

RTU

Prostate

Leica

Leica Bond

GATA-3

L50-823

RTU

Breast

Leica

Leica Bond

ER

SP1

RTU

Breast

Ventana

Ventana Ultra

PR

IE2

RTU

Breast

Ventana

Ventana Ultra

p63

4A4

RTU

Prostate

Ventana

Ventana Ultra

CDX2

EPR2764Y

RTU

Colon

Leica

Leica Bond

TTF1

8G7G3/1

1:200

Lung

Leica

Leica Bond

Napsin-A

IP64

1:400

Lung

Leica

Leica Bond

S-100 

4C4.9

RTU

Melanoma

Leica

Leica Bond

LCA (CD45)

RP2/18

RTU

Tonsil

Ventana

Ventana Ultra

CD3

LN10

1:500

Tonsil

Leica

Leica Bond

CD20

L26

1:200

Tonsil

Leica

Leica Bond

Synaptophysin

299

1:100

Pancreas

Leica

Leica Bond

Chromogranin

430

1:50

Pancreas

Leica

Leica Bond

PAX-8

Polyclonal

1:100

Thyroid Ca

Proteintech

Leica Bond

NKX3.1

Polyclonal

RTU

Prostate Ca

Leica

Leica Bond

HER2/neu

4B5

RTU

Breast Ca

Ventana

Ventana Ultra

HMWCK: high molecular cytokeratin; ER and PR: estrogen and progesterone receptor; RTU: ready-to-use.